Tag: Molnupiravir

spot_img

Molnupiravir becomes the first Oral Antiviral Drug to be included in WHO’s living Guidelines on COVID-19 Therapeutics 

WHO has updated its living guidelines on COVID-19 therapeutics. The ninth update released on 03 March 2022 include a conditional recommendation on molnupiravir.  Molnupiravir has...

Could Merck’s Molnupiravir and Pfizer’s Paxlovid, the Two New Anti-Viral Drugs Against COVID-19 Hasten the End of the Pandemic?

Molnupiravir, the world’s first oral drug (approved by MHRA, UK) against COVID-19 along with upcoming drugs such as Paxlovid and sustained vaccination drive has raised hopes...

Molnupiravir: A Game Changing Oral Pill for Treatment of COVID-19

Molnupiravir, a nucleoside analog of cytidine, a drug that has shown excellent oral bioavailability and promising results in Phase 1 and Phase 2 trials, could prove...

Stay in touch:

86,581FansLike
41,753FollowersFollow
1,772FollowersFollow
49SubscribersSubscribe

Newsletter

Don't miss

AI Designs Complete Functional Genomes

The genome language model Evo 2 has designed novel...

Voyager 2: The “Big Bang” Procedure Extends Life of Science Instruments

The “Big Bang” Energy-management procedure performed on Voyager 2...

A Black Hole That Is Not Formed from Stellar Collapse 

The black hole in the Little Red Dot (LRD)...

Meteor Produces Daytime Bolide and Sonic Boom Across New England  

A loud sonic boom was heard and a fireball seen around 18:06 UTC Saturday 30...

Carbon-free Ferrocene Analog Synthesised

The synthesis of the first carbon-free inorganic sandwich compound  (an osmium...